Sung LeeExecutive Vice President and Chief Financial Officer, Cytokinetics

Sung Lee currently serves as Executive Vice President and Chief Financial Officer at Cytokinetics, a role he assumed in May 2024. Prior to joining Cytokinetics, he held the position of Chief Financial Officer at Vir Biotechnology, MorphoSys, and Sangamo Therapeutics, where he played pivotal roles in shaping the strategy for each organization. He spent 14 years at Gilead Sciences, serving in positions of increasing responsibility, including Senior Vice President of Financial Planning & Analysis and Head, Investor Relations. Sung began his professional career in the tax advisory business at PwC, where he developed a strong foundation in finance and taxation. He earned a bachelor’s degree in economics from the University of California, Irvine, and a Master of Business Taxation from the University of Southern California.